These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9385298)

  • 1. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements.
    White RH; Zhou H; Woo L; Mungall D
    Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service.
    Kershaw B; White RH; Mungall D; Van Houten J; Brettfeld S
    Arch Intern Med; 1994 May; 154(9):1005-11. PubMed ID: 8179443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
    Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N
    Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity.
    Barletta JF; DeYoung JL; McAllen K; Baker R; Pendleton K
    Surg Obes Relat Dis; 2008; 4(6):748-53. PubMed ID: 18586569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin.
    Anand SS; Yusuf S; Pogue J; Ginsberg JS; Hirsh J;
    Circulation; 2003 Jun; 107(23):2884-8. PubMed ID: 12796128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate use of heparin. Empiric vs nomogram-based dosing.
    Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM
    Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous administration of heparin in patients with deep vein thrombosis can increase plasma levels of diamine oxidase.
    Klocker J; Perkmann R; Klein-Weigel P; Mörsdorf G; Drasche A; Klingler A; Fraedrich G; Schwelberger HG
    Vascul Pharmacol; 2004 Jan; 40(6):293-300. PubMed ID: 15063833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome.
    Joncas SX; Poirier P; Ardilouze JL; Carrier N; Fayad T; Farand P
    Obesity (Silver Spring); 2013 Sep; 21(9):1753-8. PubMed ID: 23404940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMW thrombin inhibitor, in patients with acute DVT.
    Eriksson H; Eriksson UG; Frison L; Hansson PO; Held P; Holmström M; Hägg A; Jonsson T; Lapidus L; Leijd B; Stockelberg D; Säfwenberg U; Taghavi A; Thorsén M
    Thromb Haemost; 1999 Mar; 81(3):358-63. PubMed ID: 10102460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
    Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging and heparin-related bleeding.
    Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
    Arch Intern Med; 1996 Apr; 156(8):857-60. PubMed ID: 8774204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
    Anand S; Ginsberg JS; Kearon C; Gent M; Hirsh J
    Arch Intern Med; 1996 Aug 12-26; 156(15):1677-81. PubMed ID: 8694666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL; Bailie G; Morgan S; Eisele G
    Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of heparin in males and females.
    Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
    Clin Invest Med; 1998 Apr; 21(2):71-8. PubMed ID: 9562927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assays.
    Baker BA; Adelman MD; Smith PA; Osborn JC
    Arch Intern Med; 1997 Nov; 157(21):2475-9. PubMed ID: 9385299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of low-dosage intravenous nitrate therapy on the anticoagulant effect of heparin].
    Bechtold H; Kleist P; Landgraf K; Möser K
    Med Klin (Munich); 1994 Jul; 89(7):360-6. PubMed ID: 7935224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation.
    Shalansky KF; FitzGerald JM; Sunderji R; Traboulay SJ; O'Malley B; McCarron BI; Naiman S
    Pharmacotherapy; 1996; 16(6):1076-84. PubMed ID: 8947981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of a first-order model for estimating initial heparin dosage.
    Joch LE; Lutomski DM; Williams DJ; Bottorff M
    Clin Pharm; 1993 Aug; 12(8):597-601. PubMed ID: 8222524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.